uniQure (QURE) news
Recent news
Uniqure shares jump 9.6% in US postmarket trading
UniQure N.V. (QURE) shares surged 67.5% in premarket trading following news that the U.S. Food and Drug Administration agreed to consider three-year data from its Phase I/II study of AMT-130 as the primary basis for a Biologics License Application seeking accelerated approval for Huntington’s…
AInvest Wire · Jul 30, 2026Uniqure Q2 EPS USD -1.22
Uniqure reported a net loss for the second quarter of 2026, with earnings per share (EPS) coming in at -USD 1.22 [1]. This result reflects continued financial challenges for the company, which has been navigating operational and market-related headwinds. The negative EPS indicates that the…
AInvest Wire · Jul 29, 2026U.S.-listed shares of Uniqure up 3.6% premarket after Q2 revenue beat
AInvest Wire · Jul 29, 2026Uniqure Inc.: Uniqure: Closing of upsized offering, full exercise by underwriters of option to buy added shares
AInvest Wire · Jun 25, 2026Uniqure NV - to grant underwriters 30-day option to purchase up to $22.5 mln additional shares
AInvest Wire · Jun 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.